⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTRS News
Viatris Inc. Common Stock
Postoperative Pain Management Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
VRTX
VTRS
HRTX
AXSM
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
prnewswire.com
TBPH
ZYME
VTRS
GSK
Form 8-K
sec.gov
VTRS
Viatris Reports Second-Quarter 2026 Financial Results
prnewswire.com
VTRS
Viatris Announces Quarterly Dividend
prnewswire.com
VTRS
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
prnewswire.com
VTRS
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
CYTK
NVO
BCDA
AZN
BMY
LLY
MESO
ASMB
LXRX
VTRS
AMGN
IRWD
NVS
MRK
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight
prnewswire.com
BIIB
RPRX
UCB
VTRS
NVS
KZR
GSK
AZN
ABBV
BMY
JNJ
Form 8-K
sec.gov
VTRS
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
prnewswire.com
VTRS